Skip to content
PPD Inc PPD Inc
Main Menu
  • Blog
  • Careers
  • Contact Us
  • Investors
  • News
  • Preclarus
  • Japan
Search
  • Who We Are
    • Our Mission
      • Accolades
      • Company History
    • Defining Principles
    • Our People
      • Board of Directors
    • Senior Leadership
    • Our Work
      • Our Solutions
      • How We Help
      • Therapeutic Areas
    • Corporate Responsibility
      • Environmental Stewardship
      • Health and Wellness
      • Philanthropy
      • PPD Heroes
    • Locations
    • Company Resources
      • Ethics
      • Events
      • Investors
      • Media Kit
      • PPD in the News
      • Legal Notices
      • Privacy Policy
      • Vendor Resources
  • How We Help
    • Building Patient-Driven Trials
    • Clinical Trial Certainty/Reliability
    • COVID-19
      • Resources
    • Decentralized Clinical Trials
      • Resources
    • Expertise in Asia-Pacific
      • PPD-SNBL in Japan
    • Leveraging Identified Data
    • Supporting Product Approval
    • PPD Biotech
      • Biotech Experience and Expertise Resources
    • Ensuring Business Continuity with PPD FSP
  • Our Solutions
    • Clinical Development
      • Early Development
        • Phase I
      • Phase II-IV Clinical Trial Management
        • Biostatistics
        • Clinical Trial Monitoring
        • Clinical Data Management
        • Global Clinical Supplies
        • Interactive Response Technology (IRT)
        • Medical Communications
        • Medical Writing
        • Pharmacokinetic and Pharmacodynamic
        • Pharmacovigilance
        • Project Management
      • Peri- and Post-approval
        • Data and Real-World Evidence
        • Evidence Synthesis, Modeling and Communication
        • Interventional Studies
        • Non-Interventional Studies
      • PPD Biotech
        • Biotech Experience and Expertise Resources
      • PPD FSP
        • PPD FSP Source
      • Product Development and Consulting
      • Quality and Enterprise Learning
      • Regulatory Affairs
      • Site and Patient-centric Solutions
        • Accelerated Enrollment Solutions (AES)
        • Enrollment and Site Activation
        • Integrating the Patient Voice
        • Leveraging Technology
        • PatientAdvantage
        • Reducing Patient Burden
        • Contact Site and Patient Services
      • Technology and Innovation
        • Business Process and Change Management
        • Decentralized Clinical Trials
        • Global Technology Services
        • Preclarus
        • Products and Services
      • Government and Public Health
      • Medical Device Development
    • PPD Laboratories
      • Bioanalytical Lab
        • Capabilities
        • Experience and Expertise
        • PPD® Laboratories’ Tech Talks
      • Biomarker Lab
        • Capabilities
      • Central Lab
        • Capabilities
        • Certifications
        • Preclarus Lab Solutions
      • GMP Lab
        • Capabilities
        • Experience and Expertise
        • Athlone Lab
      • Vaccine Sciences Lab
        • Capabilities
      • PPD Laboratories FSP
      • Part of the COVID-19 Solution
  • Therapeutic Areas
    • Cardiovascular
    • Cell and Gene Therapy
    • Critical Care
    • Dermatology
    • Gastroenterology
    • Immunology and Rheumatology
    • Infectious Diseases
    • Metabolic and Endocrine
    • Nephrology and Renal Disease
    • Neuroscience
    • Oncology and Hematology
    • Ophthalmology
    • Pediatrics
    • Rare Diseases
    • Respiratory
    • Urology
    • Vaccine Development
    • Women’s Health
  • Participate in a Trial
    • Austin Clinical Research Unit
      • Volunteer Opportunities
      • Who can be a volunteer
      • What to Expect
      • Online Tour
      • Study Volunteer FAQ
      • Contact Information
    • Las Vegas Clinical Research Unit
      • Volunteer Opportunities
      • Who can be a volunteer
      • What to Expect
      • Online Tour
      • Study Volunteer FAQ
      • Contact Information
    • Orlando Clinical Research Unit
    • Phase II-IIIb Clinical Trial Volunteers
    • Become a Clinical Trial Investigator
      • Advantages of Being a Clinical Trial Investigator
      • FAQ
      • SiteCoach
      • Process
      • Informed Consent
      • IRB
      • Clinical Trial Investigators Database Registration
hex

Ligand-binding Assays (LBA) vs. Liquid Chromatography-Mass Spectrometry (LC-MS) for Biologics

Our SolutionsPPD LaboratoriesBioanalytical LabBioA Experience and ExpertiseBioanalytical Lab Thought Leadership SeriesLigand-binding Assays (LBA) vs. Liquid Chromatography-Mass Spectrometry (LC-MS) for Biologics

Bill Mylott, director of biologics by LC-MS at our bioanalytical lab, discusses different approaches to use for biologics studies.

Watch the video below.

  • Legal Notices
  • Site Map
  • Modern Slavery Transparency Statement
  • Privacy Policy
©2021 PPD Inc. All Rights Reserved.
  • Contact Us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • Events